Clinical Trials · NCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Phase
Phase 3
Recruitment status
Recruiting
Sponsor
SWOG Cancer Research Network
Enrollment
1,273
Start date
Sep 2018
Locations
338 sites, 5 countries
Primary endpoint
Overall survival (OS)
View Gonadorelin compound reference